相似文献
1
[21/m-Chest pain after vaccination with mRNA vaccine : Preparation for the medical specialist examination: part 147].
Internist (Berl). 2022 Apr;63(Suppl 2):270-277. doi: 10.1007/s00108-022-01313-z. Epub 2022 Apr 1.
2
Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
Cardiol Young. 2022 Jan;32(1):146-149. doi: 10.1017/S1047951121002547. Epub 2021 Jun 28.
3
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
JAMA Netw Open. 2022 Apr 1;5(4):e228879. doi: 10.1001/jamanetworkopen.2022.8879.
4
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4.
5
Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
AJR Am J Roentgenol. 2022 Apr;218(4):651-657. doi: 10.2214/AJR.21.26853. Epub 2021 Oct 27.
6
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
Allergy Asthma Proc. 2022 Jan 1;43(1):40-43. doi: 10.2500/aap.2022.43.210101.
7
COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.
J Allergy Clin Immunol Pract. 2022 May;10(5):1377-1379. doi: 10.1016/j.jaip.2022.01.037. Epub 2022 Feb 3.
8
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.
Lancet Infect Dis. 2022 Jun;22(6):802-812. doi: 10.1016/S1473-3099(22)00054-8. Epub 2022 Mar 7.
9
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236.
10
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
本文引用的文献
1
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
BMJ. 2021 Dec 16;375:e068665. doi: 10.1136/bmj-2021-068665.
2
Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis.
Am J Cardiovasc Drugs. 2022 Jan;22(1):9-26. doi: 10.1007/s40256-021-00511-8. Epub 2021 Nov 24.
3
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.
4
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
5
[Myocarditis after COVID-19 mRNA vaccination].
Monatsschr Kinderheilkd. 2021;169(10):893-894. doi: 10.1007/s00112-021-01283-w. Epub 2021 Aug 10.
6
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
Children (Basel). 2021 Jul 18;8(7):607. doi: 10.3390/children8070607.
7
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
8
[Not Available].
Ther Umsch. 2016;73(12):731-740. doi: 10.1024/0040-5930/a000857.
9
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.
10
[Myocarditis].
Dtsch Med Wochenschr. 2009 Apr;134(16):835-44; quiz 845-8. doi: 10.1055/s-0029-1220235. Epub 2009 Apr 7.
Zotero 插件
